Founded in 2019, a China-based firm sponsored by the local municipal government focuses on investment, BD and other forms of collaboration with disruptive medical technologies. With in-depth experience from their teams covering R&D, registration, distribution and sales in China and around the world, the group is looking for domestic and cross-border partnerships in terms of investment, license-in, joint venture, distribution and others.
The firm focuses on Class II and Class III medical devices from in-development to commercialization stage, especially prototype-ready projects. The firm pays special attention to companies that are developing projects related to neuro-surgery, endoscope and minimally invasive devices, stroke, cardiovascular disease, eye disease, medical robots, etc.
The firm prefers companies with a Chinese angle and are open to discussing China rights.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.





Leave a comment